Insider Transactions in Q1 2025 at Cme Group Inc. (CME)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
11
+0.45%
|
$2,882
$262.62 P/Share
|
|
Mar 26
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
262
+0.1%
|
$68,644
$262.62 P/Share
|
|
Mar 15
2025
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.38%
|
$23,478
$258.68 P/Share
|
|
Mar 15
2025
|
Jack J Tobin MD Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
308
+1.28%
|
$79,464
$258.68 P/Share
|
|
Mar 15
2025
|
Lynne Fitzpatrick President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-1.34%
|
$186,276
$258.68 P/Share
|
|
Mar 15
2025
|
Lynne Fitzpatrick President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,451
+3.85%
|
$374,358
$258.68 P/Share
|
|
Mar 15
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-6.36%
|
$419,250
$258.68 P/Share
|
|
Mar 15
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,668
+12.55%
|
$946,344
$258.68 P/Share
|
|
Mar 15
2025
|
Jonathan L Marcus Sr MD General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
269
-3.65%
|
$69,402
$258.68 P/Share
|
|
Mar 15
2025
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Payment of exercise price or tax liability
|
Direct |
722
-2.66%
|
$186,276
$258.68 P/Share
|
|
Mar 15
2025
|
Suzanne Sprague COO & Global Head of Clearing |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+7.28%
|
$374,874
$258.68 P/Share
|
|
Mar 15
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
SELL
Payment of exercise price or tax liability
|
Direct |
1,708
-10.9%
|
$440,664
$258.68 P/Share
|
|
Mar 15
2025
|
Derek Sammann Sr MD Gl Hd Commodities Mkts |
BUY
Grant, award, or other acquisition
|
Direct |
3,883
+19.85%
|
$1,001,814
$258.68 P/Share
|
|
Mar 15
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,436
-4.71%
|
$370,488
$258.68 P/Share
|
|
Mar 15
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,451
+10.17%
|
$890,358
$258.68 P/Share
|
|
Mar 15
2025
|
Terrence A Duffy Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,468
-14.5%
|
$2,958,744
$258.68 P/Share
|
|
Mar 15
2025
|
Terrence A Duffy Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,887
+24.66%
|
$6,678,846
$258.68 P/Share
|
|
Mar 15
2025
|
Sunil Cutinho Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,816
-5.83%
|
$468,528
$258.68 P/Share
|
|
Mar 15
2025
|
Sunil Cutinho Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,099
+11.63%
|
$1,057,542
$258.68 P/Share
|
|
Mar 15
2025
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
SELL
Payment of exercise price or tax liability
|
Direct |
837
-3.37%
|
$215,946
$258.68 P/Share
|
|
Mar 15
2025
|
Timothy Francis Mc Court Sr MD Global Head Equity & FX |
BUY
Grant, award, or other acquisition
|
Direct |
1,451
+7.85%
|
$374,358
$258.68 P/Share
|
|
Mar 15
2025
|
Ken Vroman Chief Transformation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,625
-7.97%
|
$419,250
$258.68 P/Share
|
|
Mar 15
2025
|
Ken Vroman Chief Transformation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,668
+15.25%
|
$946,344
$258.68 P/Share
|
|
Mar 14
2025
|
Deborah J Lucas Director |
SELL
Open market or private sale
|
Direct |
1,500
-30.89%
|
$384,000
$256.95 P/Share
|
|
Mar 13
2025
|
Howard J Siegel Director |
SELL
Open market or private sale
|
Indirect |
10,000
-31.37%
|
$2,600,000
$260.0 P/Share
|
|
Mar 11
2025
|
Terrence A Duffy Chairman and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-36.06%
|
$7,770,000
$259.18 P/Share
|
|
Mar 03
2025
|
Suzanne Sprague COO & Global Head of Clearing |
SELL
Open market or private sale
|
Direct |
1,500
-15.73%
|
$384,000
$256.83 P/Share
|
|
Feb 27
2025
|
Hilda Harris Piell Sr MD & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
3,984
-12.84%
|
$996,000
$250.47 P/Share
|
|
Feb 27
2025
|
Jack J Tobin MD Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
43
-0.18%
|
-
|
|
Feb 13
2025
|
Ken Vroman Chief Transformation Officer |
SELL
Open market or private sale
|
Direct |
5,066
-23.26%
|
$1,266,500
$250.0 P/Share
|
|
Feb 13
2025
|
Julie Winkler Sr MD Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
11,592
-34.63%
|
$2,886,408
$249.17 P/Share
|
|
Jan 16
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Direct |
60
+2.41%
|
$13,620
$227.96 P/Share
|
|
Jan 16
2025
|
William R Shepard Director |
BUY
Open market or private purchase
|
Indirect |
1,368
+0.53%
|
$310,536
$227.96 P/Share
|